XtalPi and DoveTree Form $6 Billion AI Drug Discovery Partnership
XtalPi and DoveTree Medicines have announced a strategic collaboration worth up to $6 billion to leverage AI and robotics in drug discovery, focusing on oncology, immunology, and other therapeutic areas.